Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 10

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

C-Reactive Protein as a Possible Predictor of Trail-Making Performance in Individuals with Psychiatric Disorders

Dalkner, Nina, Reininghaus, Eva, Schwalsberger, Karin, Rieger, Alexandra, Hamm, Carlo, Pilz, René, Lenger, Melanie, Queissner, Robert, Falzberger, Valerie S., Platzer, Martina, Fellendorf, Frederike T., Birner, Armin, Bengesser, Susanne A., Weiss, Elisabeth M., McIntyre, Roger S., Mangge, Harald, Reininghaus, Bernd · 2020 · Nutrients

Abstract

Cognitive dysfunction is a prominent feature of psychiatric disorders. Studies have shown that systemic low-grade inflammation is crucial in the development of cognitive deficits across psychiatric disorders. The aim of this study was to further examine the role of inflammation and inflammatory mediators in cognitive function in psychiatric disorders. This study included 364 inpatients (53% females) with International Classification of Diseases (ICD)-10 F3 (affective disorders) and F4 (neurotic, stress-related, and somatoform disorders) diagnoses. The mean age was 52 years (22 to 69 years) and the median body mass index was 27.6. Cognitive function was assessed with the Color–Word Interference Test after Stroop and the Trail-Making Test A/B. Multiple linear regression models were calculated to assess the predictive value of C-reactive protein and the kynurenine/tryptophan ratio on cognitive function controlling for age, sex, education, premorbid verbal intelligence quotient, illness duration, depressive symptoms, and obesity-related parameters (e.g., body mass index, high-density lipoprotein). Our data confirm that in patients with psychiatric disorders, C-reactive protein serum concentration is a relevant and important predictor of Trail-Making Test B performance, measuring cognitive flexibility. The effect size of this association did not change much after adding clinical and metabolic variables into the regression model. The kynurenine/tryptophan ratio was not related to cognitive test scores. The involvement of C-reactive protein as a peripheral inflammatory marker in cognitive flexibility and psychomotor processing speed in psychiatric illness can be concluded.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu12103019

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 46

  1. Arts, 2008, Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives, Psychol Med., 38, 771, 10.1017/S0033291707001675 · DOI · Paper page
  2. Lee, 2012, A meta-analysis of cognitive deficits in first-episode major depressive disorder, J. Affect. Disord., 140, 113, 10.1016/j.jad.2011.10.023 · DOI · Paper page
  3. Robinson, 2006, A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder, J. Affect. Disord., 93, 105, 10.1016/j.jad.2006.02.016 · DOI · Paper page
  4. Millan, 2012, Cognitive dysfunction in psychiatric disorders: Characteristics, causes and the quest for improved therapy, Nat. Rev. Drug Discov., 11, 141, 10.1038/nrd3628 · DOI · Paper page
  5. Alvarez, 2006, Executive function and the frontal lobes: A meta-analytic review, Neuropsychol. Rev., 16, 17, 10.1007/s11065-006-9002-x · DOI · Paper page
  6. Martino, 2014, Longitudinal course of cognitive deficits in bipolar disorder: A meta-analytic study, J. Affect. Disord., 164, 130, 10.1016/j.jad.2014.04.028 · DOI
  7. Allison, 2014, The common inflammatory etiology of depression and cognitive impairment: A therapeutic target, J. Neuroinflammation, 11, 1, 10.1186/s12974-014-0151-1 · DOI · Paper page
  8. Fourrier, 2019, Neuroinflammation and cognition across psychiatric conditions, CNS Spectr., 24, 4, 10.1017/S1092852918001499 · DOI
  9. Howren, 2009, Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis, Psychosom Med., 71, 171, 10.1097/PSY.0b013e3181907c1b · DOI · Paper page
  10. Dixon, 2010, The effect of obesity on health outcomes, Mol Cell Endocrinol, 316, 104, 10.1016/j.mce.2009.07.008 · DOI · Paper page
  11. Penninx, 2001, Depression and cardiac mortality: Results from a community-based longitudinal study, Arch. Gen. Psychiatry, 58, 221, 10.1001/archpsyc.58.3.221 · DOI · Paper page
  12. Soczynska, 2011, Mood disorders and obesity: Understanding inflammation as a pathophysiological nexus, Neuromol. Med., 13, 93, 10.1007/s12017-010-8140-8 · DOI · Paper page
  13. Choi, 2013, Obesity and C-reactive protein in various populations: A systematic review and meta-analysis, Obes. Rev., 14, 232, 10.1111/obr.12003 · DOI · Paper page
  14. Santos, 2005, Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome, Int. J. Obes., 29, 1452, 10.1038/sj.ijo.0803035 · DOI · Paper page
  15. Dowlati, 2010, A meta-analysis of cytokines in major depression, Biol Psychiatry, 67, 446, 10.1016/j.biopsych.2009.09.033 · DOI · Paper page
  16. Teunissen, 2003, Inflammation markers in relation to cognition in a healthy aging population, J. Neuroimmunol., 134, 142, 10.1016/S0165-5728(02)00398-3 · DOI · Paper page
  17. Karalis, 2009, Mechanisms of obesity and related pathology: Linking immune responses to metabolic stress, Febs J., 276, 5747, 10.1111/j.1742-4658.2009.07304.x · DOI · Paper page
  18. Spyridaki, 2016, Obesity, inflammation and cognition, Curr. Opin. Behav. Sci., 9, 169, 10.1016/j.cobeha.2016.05.004 · DOI
  19. Furukawa, 2017, Increased oxidative stress in obesity and its impact on metabolic syndrome, J. Clin. Investig., 114, 1752, 10.1172/JCI21625 · DOI · Paper page
  20. Fagundo, A.B., de la Torre, R., Jiménez-Murcia, S., Agüera, Z., Granero, R., Tárrega, S., Botella, C., Baños, R., Fernández-Real, J.M., and Rodríguez, R. (2012). Executive functions profile in extreme eating/weight conditions: From anorexia nervosa to obesity. PLoS ONE, 7. · DOI · Paper page
  21. Fergenbaum, 2009, Obesity and lowered cognitive performance in a Canadian First Nations population, Obesity, 17, 1957, 10.1038/oby.2009.161 · DOI
  22. Hall, 2008, Executive function moderates the intention-behavior link for physical activity and dietary behavior, Psychol. Health, 23, 309, 10.1080/14768320701212099 · DOI · Paper page
  23. Riggs, 2010, Executive cognitive function as a correlate and predictor of child food intake and physical activity, Child. Neuropsychol., 16, 279, 10.1080/09297041003601488 · DOI
  24. Mangge, 2014, Disturbed tryptophan metabolism in cardiovascular disease, Curr Med. Chem, 21, 1931, 10.2174/0929867321666140304105526 · DOI
  25. Reininghaus, 2014, Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: A preliminary report, Bipolar Disord., 16, 432, 10.1111/bdi.12166 · DOI
  26. Birner, A., Platzer, M., Bengesser, S.A., Dalkner, N., Fellendorf, F.T., Queissner, R., Pilz, R., Rauch, P., Maget, A., and Hamm, C. (2017). Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder. PLoS ONE, 12. · DOI
  27. Kuo, 2005, Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: Systematic review and meta-analysis, Lancet Neurol., 4, 371, 10.1016/S1474-4422(05)70099-5 · DOI · Paper page
  28. Misiak, 2017, Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review, Schizophr. Res., 192, 16, 10.1016/j.schres.2017.04.015 · DOI · Paper page
  29. Jonsdottir, 2017, Associations between systemic pro-inflammatory markers, cognitive function and cognitive complaints in a population-based sample of working adults, J. Psychosom. Res., 96, 49, 10.1016/j.jpsychores.2017.03.010 · DOI
  30. Gimeno, 2009, Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study, Psychol. Med., 39, 413, 10.1017/S0033291708003723 · DOI · Paper page
  31. Dickerson, 2014, A longitudinal study of cognitive functioning in schizophrenia: Clinical and biological predictors, Schizophr Res., 156, 248, 10.1016/j.schres.2014.04.019 · DOI
  32. Chang, 2012, Treatment response and cognitive impairment in major depression: Association with C-reactive protein, Brain Behav. Immun., 26, 90, 10.1016/j.bbi.2011.07.239 · DOI · Paper page
  33. Krogh, 2014, The association between depressive symptoms, cognitive function, and inflammation in major depression, Brain Behav. Immun., 35, 70, 10.1016/j.bbi.2013.08.014 · DOI · Paper page
  34. Platzer, 2017, Tryptophan breakdown and cognition in bipolar disorder, Psychoneuroendocrinology, 81, 144, 10.1016/j.psyneuen.2017.04.015 · DOI
  35. Forrest, 2011, Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery, J. Neurochem., 119, 136, 10.1111/j.1471-4159.2011.07414.x · DOI
  36. Lehrl, 1995, Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence, Acta Neurol. Scand., 91, 335, 10.1111/j.1600-0404.1995.tb07018.x · DOI · Paper page
  37. Hamilton, 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
  38. Guy, W. (1976). Clinical Global Impressions, ECDEU Assessment Manual for Psychopharmacology, Revised. · DOI · Paper page
  39. Widner, 1997, Simultaneous measurement of serum tryptophan and kynurenine by HPLC, Clin. Chem., 43, 2424, 10.1093/clinchem/43.12.2424 · DOI · Paper page
  40. Sumitani, 2007, Activation of the prefrontal cortex during the Trail-Making Test detected with multichannel near-infrared spectroscopy, Psychiatry Clin. Neurosci., 61, 616, 10.1111/j.1440-1819.2007.01727.x · DOI
  41. Kortte, 2002, The trail making test, part B: Cognitive flexibility or ability to maintain set?, Appl. Neuropsychol., 9, 106, 10.1207/S15324826AN0902_5 · DOI · Paper page
  42. Demakis, 2004, Frontal lobe damage and tests of executive processing: A meta-analysis of the category test, stroop test, and trail-making test, J. Clin. Exp. Neuropsychol., 26, 441, 10.1080/13803390490510149 · DOI · Paper page
  43. Fabricatore, 2011, Intentional weight loss and changes in symptoms of depression: A systematic review and meta-analysis, Int. J. Obes., 35, 1363, 10.1038/ijo.2011.2 · DOI · Paper page
  44. Siervo, 2011, Intentional weight loss in overweight and obese individuals and cognitive function: A systematic review and meta-analysis, Obes. Rev., 12, 968, 10.1111/j.1467-789X.2011.00903.x · DOI · Paper page
  45. Sutliffe, 2015, C-reactive protein response to a vegan lifestyle intervention, Complementary Ther. Med., 23, 32, 10.1016/j.ctim.2014.11.001 · DOI
  46. Lee, 2013, Cognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients, Psychol. Med., 43, 1161, 10.1017/S0033291712002127 · DOI

Cited by

See all 10

Metadata

Authors
Dalkner, N., Reininghaus, E., Schwalsberger, K., Rieger, A., Hamm, C., Pilz, R., Lenger, M., Queissner, R., Falzberger, V. S., Platzer, M., Fellendorf, F. T., Birner, A., Bengesser, S. A., Weiss, E. M., McIntyre, R. S., Mangge, H., & Reininghaus, B.
Affiliations
  • Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, 8036 Graz, Austria
  • Therapiezentrum Justuspark, 4540 Bad Hall, Austria
  • Institute of Psychology, University of Innsbruck, 6020 Innsbruck, Austria
  • Department of Psychiatry and Pharmacology, University of Toronto, Toronto, ON 399, Canada
  • Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University, 8036 Graz, Austria
Venue
Nutrients
Publisher
MDPI AG
Published
2020-10-02
Volume
12
Issue
10
Pages
3019
ISSN
2072-6643
Cited by
10
References
19
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: C-Reactive Protein as a Possible Predictor of Trail-Making Performance in Individuals with Psychiatric Disorders. https://app.cochat.ai/papers/10.3390/nu12103019
The paper
Dalkner, N., Reininghaus, E., Schwalsberger, K., Rieger, A., Hamm, C., Pilz, R., Lenger, M., Queissner, R., Falzberger, V. S., Platzer, M., Fellendorf, F. T., Birner, A., Bengesser, S. A., Weiss, E. M., McIntyre, R. S., Mangge, H., & Reininghaus, B. (2020). C-Reactive Protein as a Possible Predictor of Trail-Making Performance in Individuals with Psychiatric Disorders. Nutrients. https://doi.org/10.3390/nu12103019

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.